Updated:
Upcoming DiaSorin dividendDiaSorin has not mentioned dividends for 2026.
DiaSorin, whose ex-dividend was May 18, 2026, credited 1.3 euros on May 20, 2026.
DiaSorin S.p.A., listed on the stock exchanges of the United Kingdom, Germany, Austria and Italy, using the DIA symbol, has been paying dividends since 2008, with an impeccable track record of making payments continuously, on time and without suspensions for more than 15 years.
The interest deposited depends on the decisions of the administrative unit and the general shareholders' meeting, who evaluate the percentage to be granted, generally in a single installment, in the last days of May, with a yield of 1.07%.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio DiaSorin Dividends
- Payout Ratio47.79%
- Retained Earnings52.21%
An appropriate payout ratio may vary depending on the industry, the company's growth stage and its financial health.
Dividend calendar of DiaSorin
There is no Dividend Calendar of DiaSorin defined for 2026.
For a company to have growing dividends by our standards, the annual dividend amount must have increased steadily for at least the last 5 years.
The company's dividend yield is compared to the industry average to determine its positioning.
Imagine you have a list of dividend yields for different companies in an industry. If you look for the "top 25% percentile", you will find a number. This number tells you that the top 25% of the companies with the highest dividends have a yield higher than that number. On the other hand, the "top 75% percentile" shows you another number, which tells you that 75% of the companies have a higher yield than that number, thus showing a more common and less high yield.
For a company to have stable dividends by our standards, it is vital that it has not had an annual decline of more than 10% over the previous year.
Dividend history of DiaSorin
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2026 |
05/18/2026 |
1.3 € |
1.3 € |
| 2025 |
05/19/2025 |
1.2 € |
1.2 € |
| 2024 |
05/20/2024 |
1.15 € |
1.15 € |
| 2023 |
05/22/2023 |
1.1 € |
1.1 € |
| 2022 |
05/23/2022 |
1.05 € |
1.05 € |
| 2021 |
05/24/2021 |
1 € |
1.0 € |
| 2020 |
06/15/2020 |
0.95 € |
0.95 € |
| 2019 |
05/20/2019 |
0.9 € |
0.9 € |
| 2018 |
12/27/2018 05/21/2018 |
1.8 € 0.85 € |
2.65 € |
| 2017 |
05/22/2017 |
0.8 € |
0.8 € |
| 2016 |
05/23/2016 |
0.65 € |
0.65 € |
| 2015 |
05/18/2015 |
0.6 € |
0.6 € |
| 2014 |
05/19/2014 |
0.55 € |
0.55 € |
| 2013 |
05/20/2013 |
0.5 € |
0.5 € |
| 2012 |
12/27/2012 05/21/2012 |
0.83 € 0.46 € |
1.29 € |
| 2011 |
06/20/2011 |
0.4 € |
0.4 € |
| 2010 |
06/21/2010 |
0.2 € |
0.2 € |
| 2009 |
06/15/2009 |
0.12 € |
0.12 € |
| 2008 |
07/14/2008 |
0.1 € |
0.1 € |
Information about DiaSorin
DiaSorin S.p.A., is a company dedicated to the biotechnology industry, specialized in the production and commercialization of instruments, reagent kits and in vitro diagnostic services, which are generally used for molecular diagnostics, immunodiagnostics and life sciences.
They have an extensive track record in performing diagnostic tests, innovating technologically and creating life science solutions, reaching more than 100 countries, on five continents, with direct operations in Europe, the United States, Israel, Brazil, Canada, Mexico, India, China and Australia with 10 factories, in addition to having nearly 200 authorized independent distributors, which has allowed them to record 1,361 million euros in revenues in 2022.
It was founded in 2000 although its history dates back to 1968 with the creation of the "Società Ricerche Impianti Nucleari - Sorin", acquiring in 1997 Sorin Biomedica and Immunonuclear Corporation, thus forming Medical System Group, which later became DiaSorin by including Sienna Biotech, Inc., obtaining its name from the union between "Dia" derived from diagnostics and "Sorin" from "Nuclear Plant Research Company".
DiaSorin's areas of expertise associated with the manufacture of test kits in the immunodiagnostic sector relate to Gastrointestinal Infections, Bone and Mineral Metabolism, Hypertension, Oncology, Infectious Diseases, Endocrinology, Oncohematology and Autoimmunity, as for molecular diagnostics, DiaSorin focuses on infectious diseases, with blood, cerebrospinal fluid, skin and mucocutaneous swab tests.
Frequently asked questions about DiaSorin dividends
DiaSorin pays dividends on a Annual basis.
DiaSorin is listed on the Borsa Italiana and is part of the FTSE MIB.
DiaSorin has the Ticker or stock code DIA.
The CEO of DiaSorin in 2026 is Mr. Carlo Rosa.
The ISIN of DiaSorin is IT0003492391.
DiaSorin has a growing dividend program. In the last 5 years, dividends have been at least equal to or higher than the previous year.
Check the latest comments and participate in the live chat on DiaSorin stocks (DIA).
No comments yet. Be the first to join in.